Publications by authors named "Francesca Guerrini"

Claim this Profile
A
An Automated Cartridge-Based Microfluidic System for Real-Time Quantification of Transcripts in Chronic Myeloid Leukemia: An Italian Experience.
Alice Costanza Danzero, Enrico Marco Gottardi, Fabrizio Quarantelli, Ciro Del Prete, Alessandra Potenza, Francesca Guerrini

Int J Mol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new digital droplet PCR method for looking at epigenetics in diffuse large B-cell lymphomas: The role of BMI1, EZH2, and USP22 genes.
Alessio Lusci Gemignani, Robel Papotti, Riccardo Bomben, Valter Gattei, Samantha Pozzi, Francesca Guerrini

Int J Lab Hematol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool.
Sara Galimberti, Serena Balducci, Francesca Guerrini, Marzia Del Re, Rossella Cacciola

Diagnostics (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation.
Federica Ricci, Serena Balducci, Francesca Guerrini, Susanna Grassi, Elena Ciabatti

Clin Hematol Int· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2.
Sara Galimberti, Mario Petrini, Claudia Baratè, Federica Ricci, Serena Balducci, Francesca Guerrini

Front Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Droplet PCR is a Specific and Sensitive Tool for Detecting IDH2 Mutations in Acute Myeloid LeuKemia Patients.
Susanna Grassi, Francesca Guerrini, Elena Ciabatti, Riccardo Puccetti, Serena Salehzadeh

Cancers (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice.
Sara Galimberti, Elisa Genuardi, Francesco Mazziotta, Lorenzo Iovino, Fortunato Morabito, Francesca Guerrini

Front Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia.
Susanna Grassi, Sara Palumbo, Veronica Mariotti, Diego Liberati, Francesca Guerrini

Front Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients.
Serena Salehzadeh, Francesca Guerrini, Umberto Pizzano, Susanna Grassi, Elena Ciabatti

Cancer Cell Int· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia.
Sara Galimberti, Susanna Grassi, Claudia Baratè, Francesca Guerrini, Elena Ciabatti

Front Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naïve lymphocytes and prevents TTV reactivation.
Lorenzo Iovino, Francesco Mazziotta, Giovanni Carulli, Francesca Guerrini, Riccardo Morganti

Leuk Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly sensitive mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia.
Daniela Drandi, Elisa Genuardi, Irene Dogliotti, Martina Ferrante, Cristina Jiménez, Francesca Guerrini

Haematologica· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRDI-BF1 and PRDI-BF1P isoform expressions correlate with disease status in multiple myeloma patients.
Gabriele Buda, Francesca Guerrini, Sara Galimberti, Enrico Orciuolo, Simone Pacini

Hematol Rep· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup.
Elena Ciabatti, Angelo Valetto, Veronica Bertini, Maria Immacolata Ferreri, Alice Guazzelli, Francesca Guerrini

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The and polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia.
Sara Galimberti, Cristina Bucelli, Elena Arrigoni, Claudia Baratè, Susanna Grassi, Francesca Guerrini

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study.
Sara Galimberti, Elena Ciabatti, Giacomo Ercolano, Susanna Grassi, Francesca Guerrini

Front Pharmacol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia.
Laura Galeotti, Francesco Ceccherini, Dario Domingo, Marco Laurino, Marialuisa Polillo, Francesca Guerrini

Cancer Chemother Pharmacol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of V600E Mutation in Hairy Cell Leukemia.
Francesca Guerrini, Matteo Paolicchi, Francesco Ghio, Elena Ciabatti, Susanna Grassi

Front Pharmacol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced circulating B-lymphocytes and altered B-cell compartments in patients suffering from chronic myeloid leukaemia undergoing therapy with Imatinib.
Giovanni Carulli, Claudia Baratè, Alessandra Marini, Virginia Ottaviano, Giulia Cervetti, Francesca Guerrini

Hematol Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased values of the circulating PDGFβ sustains the "withdrawal syndrome" after tyrosine kinase inhibitor discontinuation in patients affected by chronic myeloid leukemia.
Sara Galimberti, Giulia Fontanelli, Sara Barsotti, Federica Ricci, Francesca Guerrini

Blood Cells Mol Dis· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polycomb genes are associated with response to imatinib in chronic myeloid leukemia.
Francesco Crea, Antonello Di Paolo, Hui Hsuan Liu, Marialuisa Polillo, Pier-Luc Clermont, Francesca Guerrini

Epigenomics· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial.
Sara Galimberti, Stefano Luminari, Elena Ciabatti, Susanna Grassi, Francesca Guerrini

Clin Cancer Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study.
Sara Galimberti, Francesca Guerrini, Flavia Salvi, Iacopo Petrini, Daniela Gioia

J Hematol Oncol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ITF2357 interferes with apoptosis and inflammatory pathways in the HL-60 model: a gene expression study.
Sara Galimberti, Martina Canestraro, Hakan Savli, Giuseppe Alberto Palumbo, Daniele Tibullo, Francesca Guerrini

Anticancer Res· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders.
Martina Canestraro, Sara Galimberti, Hakan Savli, Giuseppe Alberto Palumbo, Daniele Tibullo, Francesca Guerrini

Cancer Genet Cytogenet· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis